BIO

BIO Financing Cash Flow

-$121.10MTTM · USD

Period ending:

BIO FY Cash from FinancingUSD
BIO FY Cash from Financing1989-12-31: $6.00M1990-12-31: $7.40M1991-12-31: $25.40M1992-12-31: $1.70M1993-12-31: -$15.20M1994-12-31: -$32.90M1995-12-31: -$13.10M1996-12-31: -$25.20M1997-12-31: $33.50M1998-12-31: -$900.00K1999-12-31: $182.30M2000-12-31: -$41.61M2001-12-31: -$20.16M2002-12-31: -$79.13M2003-12-31: $108.17M2004-12-31: $193.23M2005-12-31: $1.29M2006-12-31: $10.16M2007-12-31: -$7.45M2008-12-31: $6.33M2009-12-31: $293.93M2010-12-31: $228.75M2011-12-31: -$213.56M2012-12-31: $12.59M2013-12-31: -$311.70M2014-12-31: $11.69M2015-12-31: $8.58M2016-12-31: $9.02M2017-12-31: $341.00K2018-12-31: -$48.68M2019-12-31: -$22.76M2020-12-31: -$523.04M2021-12-31: -$55.43M2022-12-31: $973.58M2023-12-31: -$425.65M2024-12-31: -$218.80M2025-12-31: -$283.20M$973.58M-$523.04M
1989-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

BIO financing cash flow history

Cash from issuing/repaying debt and equity. The available annual fiscal periods series contains 37 observations from Dec 31, 1989 to Dec 31, 2025.

Bio-Rad Laboratories, Inc. Class A Common Stock Financing Cash Flow — Annual fiscal periods (USD)
Period endingFinancing Cash Flow (USD)
-283,200,000
-218,800,000
-425,647,000
973,576,000
-55,429,000
-523,041,000
-22,758,000
-48,680,000
341,000
9,020,000
8,581,000
11,689,000
-311,697,000
12,588,000
-213,560,000
228,745,000
293,933,000
6,331,000
-7,450,000
10,162,000
1,290,000
193,227,000
108,169,000
-79,127,000
-20,162,000
-41,606,000
182,300,000
-900,000
33,500,000
-25,200,000
-13,100,000
-32,900,000
-15,200,000
1,700,000
25,400,000
7,400,000
6,000,000

Compare financing cash flow

All BIO financial metrics · BIO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.